Absorbable stent shows promise for Biotronik in first coronary artery trial
This article was originally published in Clinica
Executive Summary
The first human coronary artery trial of an absorbable metal stent have produced promising early results. Four-month follow-up data from the 63-patient study has shown the product to be a safe and feasible treatment option for blocked coronary vessels.